Advancing Global Health Equity in Oncology Clinical Trial Access
Cet article identifie les facteurs entravant l'accès aux essais cliniques en cancérologie et présente des stratégies d'amélioration
Despite exponentially increased industry investment in oncology research and development with more than $80 billion spent annually, patient enrollment in clinical trials remains below 5% globally. Our multistakeholder international cancer coalition envisions ecosystem transformation with capacity building through a global “hub-and-spoke” network model to expand access to and accelerate clinical trials, thus ending cancer as a major cause of death in this lifetime.
Cancer Discovery , article en libre accès, 2023